• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Allergan

Allergan

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Medical Aesthetics Market to Reach $13 Billion by 2021 - Key Vendors are Cynosure, Syneron Medical, Allergan & Galderma - Research and Markets

    Global Medical Aesthetics Market to Reach $13 Billion by 2021 - Key Vendors are Cynosure, Syneron Medical, Allergan & Galderma - Research and Markets

  2. Global ENT Disorder Treatment Market 2017-2021 - Key Players are ALK, GSK, Novartis & Sanofi - Research and Markets

    Global ENT Disorder Treatment Market 2017-2021 - Key Players are ALK, GSK, Novartis & Sanofi - Research and Markets

  3. Keratoconjunctivitis Sicca (Dry Eye) Therapeutics Pipeline Report, H1 2017 - Review of 40 Companies & Drug Profiles - Research and Markets

    Keratoconjunctivitis Sicca (Dry Eye) Therapeutics Pipeline Report, H1 2017 - Review of 40 Companies & Drug Profiles - Research and Markets

  4. Pierre Fabre Pharmaceuticals Acquires Promising Assets from Igenica Biotherapeutics in the Field of Immuno-Oncology

    Pierre Fabre Pharmaceuticals Acquires Promising Assets from Igenica Biotherapeutics in the Field of Immuno-Oncology

  5. Aesthetic Market in US to Grow at a CAGR of 8% by 2021 - Driven by Shift from Invasive to Minimally Invasive & Non-invasive Procedures - Research and Markets

    Aesthetic Market in US to Grow at a CAGR of 8% by 2021 - Driven by Shift from Invasive to Minimally Invasive & Non-invasive Procedures - Research and Markets

  6. Aegon to Sell Majority of U.S. Runoff Businesses to Wilton Re

    Aegon to Sell Majority of U.S. Runoff Businesses to Wilton Re

  7. EUROPE MARKETS: European Stocks Finish Lower After Merkel Says Euro 'too Weak'

    EUROPE MARKETS: European Stocks Finish Lower After Merkel Says Euro 'too Weak'

  8. UPDATE: European stocks finish lower after Merkel says euro 'too weak'

    UPDATE: European stocks finish lower after Merkel says euro 'too weak'

  9. Global Pain Management Drugs Market Analysis 2011-2017 & 2021: Focus on Opioids, NSAIDs, Anti-Migraine, Anticonvulsants - Research and Markets

    Global Pain Management Drugs Market Analysis 2011-2017 & 2021: Focus on Opioids, NSAIDs, Anti-Migraine, Anticonvulsants - Research and Markets

  10. Renal Cluster Drug Development Pipeline Review 2017 - Therapeutics Development & Assessment - Research and Markets

    Renal Cluster Drug Development Pipeline Review 2017 - Therapeutics Development & Assessment - Research and Markets

12345

©2017 Morningstar Advisor. All right reserved.